Drug makers use safety rules to block generics
April 16, 2013
For decades, pharmaceutical companies have deployed an array of tactics aimed at preventing low-cost copies of their drugs from entering the marketplace. But federal regulators contend the latest strategy — which relies on a creative interpretation of drug safety laws — is illegal. (New York Times)
